申请人:Shenzhen TargetRx, Inc.
公开号:US11358973B2
公开(公告)日:2022-06-14
A di(hetero)aryl macrocyclic compound having an inhibitory effect on protein kinase activity, preparation and the use thereof. Specifically, disclosed are a di(hetero)aryl macrocyclic compound represented by formula (I), or a pharmaceutically acceptable salt, an enantiomer, a diastereomer, a racemate, a solvate, a hydrate, a polymorph, a prodrug or an active metabolite thereof, a pharmaceutical composition comprising said compound and the derivative thereof, and methods of using the same, including methods of treating cancers, pain, neurological diseases, autoimmune diseases and inflammation.
一种对蛋白激酶活性具有抑制作用的二(杂)芳基大环化合物及其制备方法和用途。具体而言,公开了一种由式(I)代表的二(杂)芳基大环化合物,或其药学上可接受的盐、对映体、非对映体、外消旋体、溶解物、水合物、多晶型物、原药或活性代谢物,一种包含所述化合物及其衍生物的药物组合物,以及使用方法,包括治疗癌症、疼痛、神经系统疾病、自身免疫性疾病和炎症的方法。